Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India

BACKGROUND: EMPOwER, a 12-week, double-blind (DB), randomized, placebo-controlled study evaluated the efficacy and safety of erenumab in adult patients with episodic migraine (EM) from Asia, the Middle East, and Latin America. This study analyzes the Indian experience for the use of erunumab for pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Debashish, Chaudhuri, Jaydip R., Ghosh, Pahari, Kulkarni, Rahul, Singh, Sumit, Thakur, Sneha, Thorat, Anup V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350805/
https://www.ncbi.nlm.nih.gov/pubmed/35936611
http://dx.doi.org/10.4103/aian.aian_199_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350805/
https://www.ncbi.nlm.nih.gov/pubmed/35936611
http://dx.doi.org/10.4103/aian.aian_199_22

Ejemplares similares